Skip to main content
. 2013 Dec 4;306(3):F359–F366. doi: 10.1152/ajprenal.00330.2013

Fig. 1.

Fig. 1.

Preliminary experiments to determine effective tolvaptan minipump loading. Daily urine osmolality measurements were obtained during the 4 days after subcutaneous minipump insertion. Minipumps contained concentrations of tolvaptan to give infusion rates of 0, 0.5, 2.5, and 5.0 mg/day.